# Efficacy of PosBion® Postbiotic Supplementation in Adults With Irritable Bowel Syndrome

> **NCT07699926** · NA · COMPLETED · sponsor: **My Myracle Sdn.Bhd** · enrollment: 55 (actual)

## Conditions studied

- IBS (Irritable Bowel Syndrome)
- IBD (Inflammatory Bowel Disease)
- Gut Health

## Interventions

- **DIETARY_SUPPLEMENT:** Postbiotic supplementation

## Key facts

- **NCT ID:** NCT07699926
- **Lead sponsor:** My Myracle Sdn.Bhd
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2026-01-01
- **Primary completion:** 2026-05-31
- **Final completion:** 2026-06-30
- **Target enrollment:** 55 (ACTUAL)
- **Last updated:** 2026-07-14

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07699926

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07699926, "Efficacy of PosBion® Postbiotic Supplementation in Adults With Irritable Bowel Syndrome". Retrieved via MORVS 2026-10-22 from https://api.morvs.ai/clinical/NCT07699926. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*